Cargando…
Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
The measurement of tumour cell proliferation is becoming increasingly recognised in defining prognostic groups. Proliferating cell nuclear antigen (PCNA) immunolocalisation can be used as an index of cell proliferation and may define the extent of departure from normal growth control. The monoclonal...
Autores principales: | Thomas, H., Nasim, M. M., Sarraf, C. E., Alison, M. R., Love, S., Lambert, H. E., Price, P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033602/ https://www.ncbi.nlm.nih.gov/pubmed/7841053 |
Ejemplares similares
-
Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
por: Lipponen, P. K., et al.
Publicado: (1992) -
Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
por: Klemi, P. J., et al.
Publicado: (1992) -
Proliferating Cell Nuclear Antigen (PCNA) Interactions in Solution Studied by NMR
por: De Biasio, Alfredo, et al.
Publicado: (2012) -
Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas
por: Okuno, Y, et al.
Publicado: (1999) -
Correction: Proliferating Cell Nuclear Antigen (PCNA) Interactions in Solution Studied by NMR
Publicado: (2014)